S. G. AYDIN Et Al. , "Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients with Metastatic Non-Small Cell Lung Cancer," ACTA ONCOLOGICA TURCICA , vol.54, no.3, pp.281-290, 2021
AYDIN, S. G. Et Al. 2021. Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients with Metastatic Non-Small Cell Lung Cancer. ACTA ONCOLOGICA TURCICA , vol.54, no.3 , 281-290.
AYDIN, S. G., AÇIKGÖZ, Ö., KUTLU, Y., BİLİCİ, A., HAMDARD, J., ÖLMEZ, Ö. F., ... YILDIZ, Ö.(2021). Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients with Metastatic Non-Small Cell Lung Cancer. ACTA ONCOLOGICA TURCICA , vol.54, no.3, 281-290.
AYDIN, Sabin Et Al. "Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients with Metastatic Non-Small Cell Lung Cancer," ACTA ONCOLOGICA TURCICA , vol.54, no.3, 281-290, 2021
AYDIN, Sabin G. Et Al. "Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients with Metastatic Non-Small Cell Lung Cancer." ACTA ONCOLOGICA TURCICA , vol.54, no.3, pp.281-290, 2021
AYDIN, S. G. Et Al. (2021) . "Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients with Metastatic Non-Small Cell Lung Cancer." ACTA ONCOLOGICA TURCICA , vol.54, no.3, pp.281-290.
@article{article, author={Sabin Göktaş AYDIN Et Al. }, title={Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients with Metastatic Non-Small Cell Lung Cancer}, journal={ACTA ONCOLOGICA TURCICA}, year=2021, pages={281-290} }